Summary

Europe Alternative Protein Market is valued at approximately USD 4.28 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 8.61% over the forecast period 2024-2032. Alternative proteins encompass a diverse range of protein sources that diverge from traditional animal agriculture. These sources include plant-based proteins derived from cereals, rice, oats, legumes, roots, and wheat, as well as proteins sourced from insects like coleoptera, lepidoptera, hymnoptera, orthoptera, hemiptera, diptera, among others, or microbial origins such as bacteria, algae, fungi, or yeast. The surge in interest in alternative proteins is a response to growing environmental awareness regarding the detrimental effects of conventional animal agriculture. The environmental impact of animal agriculture, including greenhouse gas emissions, deforestation, and water pollution, has spurred the exploration of alternative protein sources as a sustainable solution. The burgeoning popularity of plant-based alternatives in the food and beverage sector underscores a broader shift towards plant-centric diets, bolstered by innovative product offerings that are broadening the market landscape. Evolving consumer preferences, driven by health considerations, environmental consciousness, concern for animal welfare, and a preference for sustainable food options, have catalyzed a significant increase in demand for alternative protein products. The growing awareness regarding the environmental impact of livestock farming is a key trend for the Europe Alternative Protein Market during the estimated period of 2024-2032.

Increasing concerns regarding animal welfare and food safety are anticipated to drive the demand for alternative proteins in animal feed applications. Ethical considerations regarding the treatment of animals in industrial farming operations are leading consumers to seek out plant-based and lab-grown proteins as more humane alternatives. The growing need for plant-based proteins and food items, is expected to bolster the demand for alternative proteins and positively influence overall market growth. Europe's diverse population includes individuals with various dietary preferences, including vegetarians, vegans, flexitarians, and those with religious dietary restrictions, creating a significant market for alternative protein products. Moreover, the rising consumption of poultry meat as a high-protein option and a less environmentally impactful source of animal protein compared to red meat is propelling the demand for poultry feed, thereby likely increasing revenue within the Alternative Protein Market. Therefore, this development, along with changes in consumer diets and growing environmental awareness, have resulted in to the rise in demand for plant-based proteins. However, increased price of substitute proteins and the allergens connected to certain substitute proteins, such plant- and insect-based proteins, are anticipated to impede market expansion between 2022 and 2032.

The key countries considered for the Europe Alternative Protein Market study includes UK, Germany, France, Italy, Spain, and Rest of Europe. In 2023, Germany was the largest market. The increasing investments in research and development for product innovations within the food and beverage sector, coupled with a focus on enhancing animal nutrition and health, are poised to contribute significantly to regional industry expansion. Also, the rise in disposable income is increasing the purchasing capacity of the consumer leveraging growth opportunities over the anticipated years. According to Statista, Germany experienced a significant increase in household disposable income, reaching USD 3.15 trillion in 2022, up from USD 2.88 trillion in 2019. Furthermore, favorable regulatory frameworks and policies promoting sustainable food production and consumption are encouraging the growth of the alternative protein market across the region. Whereas, the market in the UK is expected to develop at the fastest rate over the forecast period.

Major market player included in this report are:
Kerry Group Plc
Glanbia PLC
Tate & Lyle PLC
Corbion NV
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10

The detailed segments and sub-segment of the market are explained below:

By Product
Plant Protein
Microbe-based Protein
Insect Protein

By Application
Food & Beverages
Infant Formulations
Clinical Nutrition
Animal Feed
Others

By Region:
Europe
UK
Germany
France
Spain
Italy
ROE

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market

ページTOPに戻る

Table of Contents

Chapter 1. Europe Alternative Protein Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates

Chapter 2. Executive Summary
2.1. Europe Alternative Protein Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By Product
2.3.2. By Application
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
Chapter 3. Europe Alternative Protein Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. Europe Alternative Protein Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Europe Alternative Protein Market Size & Forecasts by Product 2022-2032
5.1. Plant Protein
5.2. Microbe-based Protein
5.3. Insect Protein
Chapter 6. Europe Alternative Protein Market Size & Forecasts by Application 2022-2032
6.1. Food & Beverages
6.2. Infant Formulations
6.3. Clinical Nutrition
6.4. Animal Feed
6.5. Others
Chapter 7. Europe Alternative Protein Market Size & Forecasts by Country 2022-2032
7.1. U.K. Alternative Protein Market
7.1.1. Product breakdown size & forecasts, 2022-2032
7.1.2. Application breakdown size & forecasts, 2022-2032
7.2. Germany Alternative Protein Market
7.3. France Alternative Protein Market
7.4. Spain Alternative Protein Market
7.5. Italy Alternative Protein Market
7.6. Rest of Europe Alternative Protein Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Kerry Group Plc
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Glanbia PLC
8.3.3. Tate & Lyle PLC
8.3.4. Corbion NV
8.3.5. Company 5
8.3.6. Company 6
8.3.7. Company 7
8.3.8. Company 8
8.3.9. Company 9
8.3.10. Company 10
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes